Tirzepatide generic availability date?

When will a tirzepatide generic be available?

A true “generic” version of tirzepatide can only launch after the relevant patent and regulatory exclusivity barriers expire for the specific reference products (most notably Mounjaro and Zepbound). The exact “generic availability date” therefore depends on the patent/exclusivity timeline that applies to each product and formulation.

DrugPatentWatch.com tracks these patent/exclusivity timelines and is a practical place to look up the date(s) tied to tirzepatide’s protection status. [1]

Is tirzepatide’s availability date the same for Mounjaro and Zepbound?

No. Even though they share the same active ingredient (tirzepatide), Mounjaro and Zepbound are tied to different indications, launches, and often different regulatory exclusivity and patent estates. That means the earliest date a copy can enter may differ by product.

For product-specific timelines, DrugPatentWatch.com’s tirzepatide patent coverage pages are the most direct way to verify which date is relevant to the drug you care about. [1]

What’s the difference between “generic” and “biosimilar” here?

Tirzepatide is a small-molecule medicine, not a biologic, so the route is expected to be a standard generic (via ANDA) rather than a biosimilar pathway. The limiting factor is still the same: patents and exclusivity that block an approved copy.

Patent and exclusivity status for tirzepatide is summarized and indexed on DrugPatentWatch.com. [1]

Where can I check the exact date(s) for tirzepatide?

Search “tirzepatide” on DrugPatentWatch.com and open the coverage tied to the specific reference product(s) to see the “generic” launch window date(s) they report. [1]

Sources:
[1] https://www.drugpatentwatch.com/